HepaRegeniX is a developer of clinical-stage novel therapy for the treatment of acute and chronic liver diseases.
Business Model:
Revenue: $2M
Employees: 2-10
Address: Alfred-Mendler-Weg 25/1
City: Ulm
State: baden-württemberg
Zip: 89075
Country: DE
HepaRegeniX is a developer of clinical-stage novel therapy for the treatment of acute and chronic liver diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Series B | $12.2M |
Boehringer Ingelheim Venture Fund GmbH Novo Holdings A/S High-Tech Grunderfonds Management GmbH Coparion GmbH & Co. KG Ascenion Gmbh |
12/2016 | Series A | 4 | $9.5M |
Boehringer Ingelheim Venture Fund coparion High-Tech Grunderfonds Novo Holdings Boehringer Ingelheim Venture Fund coparion High-Tech Grunderfonds Novo Holdings |
1/2020 | Series B | 5 | $12.2M |
Ascenion GmbH Boehringer Ingelheim Venture Fund coparion High-Tech Grunderfonds Novo Holdings Ascenion GmbH Boehringer Ingelheim Venture Fund coparion High-Tech Grunderfonds Novo Holdings |
1/2017 | Series A | $9.4M |
Boehringer Ingelheim Venture Fund Novo Seeds |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|